Advertisement

A Study of Immunogenicity of Intensified Hepatitis B Vaccination in Children Being Treated for Acute Lymphoblastic Leukemia

  • 16 Accesses

Abstract

Children with acute lymphocytic leukemia (ALL) are at an increased risk of acquiring hepatitis B infection due to repeated exposure to blood products. They have poor response to vaccination due to immunosuppressive effects of malignant disease and chemotherapy; hence necessitating vaccination with increased doses or increased amount of vaccine or both. The authors studied 44 patients (32 boys and 12 girls) given double dose hepatitis B vaccination at 0, 1 and 2 mo during induction and consolidation phase of therapy. Of the thirty patients who completed the study, only 13 (43.34%) developed protective antibody levels (titres >10 mIU/ml) measured 4 wk after the third dose. The authors conclude that with three double dose schedule of Hepatitis B vaccination, response rate is poor. Therefore, for protection from Hepatitis B infection during initial phase of therapy, there is a need to provide passive immunization.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.

References

  1. 1.

    Sevinir B, Meral A, Günay Ü, Özkan T, Özuysal S, Sinirtas M. Increased risk of chronic hepatitis in children with cancer. Med Pediatr Oncol. 2003;40:104–10.

  2. 2.

    Somjee S, Pai S, Kelkar R, Advani S. Hepatitis B vaccination in children with acute lymphoblastic leukemia: results of an intensified immunization schedule. Leuk Res. 1999;23:365–7.

  3. 3.

    Goyal S, Pai SK, Kelkar R, Advani SH. Hepatitis B vaccination in acute lymphoblastic leukemia. Leuk Res. 1998;22:193–5.

  4. 4.

    Cesaro S, Giacchino M, Fioredda F, et al. Guidelines on vaccinations in paediatric haematology and oncology patients. Biomed Res Int. 2014;2014:707691.

  5. 5.

    Ghosh N, Mannan MA, Monjur F, Rizwan F, Salim AFM. Escalated regimen of hepatitis B vaccine in childhood hematological malignancies while on chemotherapy. Southeast Asian J Trop Med Public Health. 2010;41:555–61.

  6. 6.

    Ramesh M, Marwaha RK, Chawla YK, Trehan A. Seroconversion after hepatitis B vaccination in children receiving cancer chemotherapy. Indian Pediatr. 2000;37:882–6.

  7. 7.

    Meral A, Sevinir B, Günay U. Efficacy of immunization against hepatitis B virus infection in children with cancer. Med Pediatr Oncol. 2000;35:47–51.

  8. 8.

    Hovi L, Valle M, Siimes MA, Jalanko H, Saarinen UM. Impaired response to hepatitis B vaccine in children receiving anticancer chemotherapy. Pediatr Infect Dis J. 1995;14:931–5.

Download references

Author information

All authors contributed equally. JC will act as guarantor for this paper.

Correspondence to Jagdish Chandra.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nayak, S., Gupta, S., Kumar, P. et al. A Study of Immunogenicity of Intensified Hepatitis B Vaccination in Children Being Treated for Acute Lymphoblastic Leukemia. Indian J Pediatr (2020) doi:10.1007/s12098-019-03147-4

Download citation

Keywords

  • Vaccination
  • Hepatitis B
  • Leukemia
  • ALL